TOKYO and NEWARK, Del., April 30, 2026 /PRNewswire/ -- ACROBiosystems, a company dedicated to being...
TOKYO and NEWARK, Del., April 30, 2026 /PRNewswire/ -- ACROBiosystems, a company dedicated to being...
SAN DIEGO and NEWARK, Del., April 28, 2026 /PRNewswire/ -- Recently, ACROBiosystems was honored as ...
SAN DIEGO and NEWARK, N.J., April 28, 2026 /PRNewswire/ -- From April 17 to 22, 2026, ACROBiosystem...
SAN FRANCISCO, Feb. 2, 2026 /PRNewswire/ -- On January 11, as the global healthcare industry gather...
SAN FRANCISCO, Jan. 26, 2026 /PRNewswire/ -- To enable Chinese innovative pharmaceutical companies ...
ACROBiosystems and Partners Conclude OrganoAsia 2025 - Leading Scientists from China, Japan and S...
In the news release, ACROBiosystems and Partners Conclude OrganoAsia 2025, issued10-Oct-2025 by AC...
SEOUL, South Korea, Aug. 28, 2025 /PRNewswire/ -- ACROBiosystems, a global biotechnology company de...
China's influential innovative drug asset cooperation platform NEWARK, Del., June 9, 2025 /PRNewsw...
NEWARK, Del., June 5, 2025 /PRNewswire/ -- China's influential innovative drug asset cooperation pl...
NEWARK, Del., Dec. 2, 2024 /PRNewswire/ -- ACROBiosystems' US Innovation Lab has recently achieved ...
NEWARK, Del., Sept. 29, 2024 /PRNewswire/ -- SeromYx Systems, a cutting-edge immunology technology ...
NEWARK, Del., July 18, 2024 /PRNewswire/ -- At the recent International Society for Stem Cell Resea...
NEWARK, Del., June 26, 2024 /PRNewswire/ -- bioSeedin, a flourishing global licensing and consultin...
NEWARK, Del., April 10, 2024 /PRNewswire/ -- Starting in 2023, ACROBiosystems has been continuously...
TOKYO, April 10, 2024 /PRNewswire/ -- Starting in 2023, ACROBiosystems has been launching a continu...
NEWARK, Calif., March 4, 2024 /PRNewswire/ -- ACROBiosystems, one of the leading providers of innov...
NEWARK, Del., Nov. 16, 2023 /PRNewswire/ -- ACROBiosystems, a global cornerstone of the pharmaceut...
BOSTON, Oct. 9, 2023 /PRNewswire/ -- Recently, the fifth Biopharma Developer Innovation Conference ...